Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Plasma Therapy Market Growth Performance Trended Historically, And What Lies Ahead?

In the past few years, the plasma therapy market has experienced swift expansion. It is projected to escalate from $0.49 billion in 2024 to $0.55 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.4%. The historic progression is majorly attributable to the increased occurrence of long-standing illnesses, heightened consciousness about plasma therapy benefits, governmental backing for the therapy, reimbursement provisions for the treatment, a surge in the preference for minimally invasive methodologies, an increasing call for personalized medicine, along with the expanding aging population.

What Is the Forecast for the Plasma Therapy Market Size Through 2029?

There is expected to be a swift expansion in the size of the plasma therapy market in the upcoming years, hitting a mark of $0.88 billion by 2029, enjoying a compound annual growth rate (CAGR) of 12.5%. The surge in growth during the forecast period can be traced back to a higher prevalence of immunoglobulin acceptance, broadening uses, a spike in the need for treatment of rare diseases, and individualized treatment plans. The forecast period will likely bring some notable trends including advancements in plasma therapy techniques, biological manufacturing, the use of cell-free plasma therapies, telemedicine integration, and exploration into novel applications.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

What are the Key Market Players in Plasma Therapy Market and How They’re Evolving?

Major companies operating in the plasma therapy market include Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

What Are the Primary Growth Drivers in the Plasma Therapy Market?

An uptick in osteoarthritis instances is anticipated to propel the plasma therapy market in the coming years. Platelet-rich plasma (PRP), a variant of plasma therapy, is deemed a reliable and effective solution for osteoarthritis. PRP consists of a dense autologous blood growth factor that is introduced into the joint to diminish inflammation and delay the advancement of osteoarthritis. As an example, a forecast from the Journal of Elsevier, a Dutch publisher, in September 2023 states that by 2050, osteoarthritis occurrences worldwide are projected to increase by 74.9% (with a range of 59.4% to 89.9%) for the knee, 48.6% (with a range of 35.9% to 67.1%) for the hand, 78.6% (with a range of 57.7% to 105.3%) for the hip, and 95.1% (with a range of 68.1% to 135.0%) for other osteoarthritis forms. Some common treatments include autologous chondrocyte implantation and scaffold implants. Consequently, the increased frequency of osteoarthritis can be seen as a primary driver for the plasma therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3278&type=smp

What Are the Leading Segments in the Global Plasma Therapy Industry?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

What Are the Key Market Trends in the Plasma Therapy Industry?

To accommodate the changing requirements and improve treatment alternatives, large corporations in the plasma therapy market are developing innovative products like the ESG-410. The ESG-410, an Electrosurgical Generator, was designed to bolster treatment options for non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia. Notably, in June 2023, Olympus Corporation, a medical technology firm based in Japan, unveiled its next-generation electrosurgical generator, the ESG-410, for the treatment of bladder cancer and prostate enlargement. The ESG-410 touts modern design highlights including improved capacitors for heightened plasma stability during ignition. Compared to the ESG-400, it provides rapid ignition and enhanced plasma stability, particularly when coupled with different loop sizes and oval buttons. The ESG-410 Electrosurgical Generator enhances treatment options for NMIBC and BPH by offering an assortment of resection loops, electrodes, and vaporization apparatus.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

What Is the Regional Outlook for the Plasma Therapy Market?

The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3278

This Report Delivers Insight On:

1. How big is the plasma therapy market, and how is it changing globally?

2. Who are the major companies in the plasma therapy market, and how are they performing?

3. What are the key opportunities and risks in the plasma therapy market right now?

4. Which products or customer segments are growing the most in the plasma therapy market?

5. What factors are helping or slowing down the growth of the plasma therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model